TAP Pharmaceuticals Products Inc.

January 11 2005

Notice is being given for consumers, insurers, employee welfare benefit plans and other entities who paid for Lupron(R) about a proposed $150 million settlement. A class action lawsuit claimed there was a fraudulent scheme about the marketing, sale, and distribution of Lupron(R) that caused class members to overpay. (Jan-07-05) [YAHOO] [SETTLEMENT CLAIM]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in the form to the right to submit your complaint.